Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gordon Sussman

Showing results (31-40 of 67) with videos related to

Pageof 7
Sort By:
The Journal of Allergy and Clinical Immunology. in Practice|November 20, 2020
Anti-PEG IgE in anaphylaxis associated with polyethylene glycolZhao-Hua Zhou, Cosby A Stone, Baruch Jakubovic, et al.
The Journal of Allergy and Clinical Immunology. in Practice|April 10, 2020
Omalizumab Re-Treatment and Step-Up in Patients with Chronic Spontaneous Urticaria: OPTIMA TrialGordon Sussman, Jacques Hébert, Wayne Gulliver, et al.
Allergy|August 5, 2018
Total IgE levels are linked to the response of chronic spontaneous urticaria patients to omalizumabKarsten Weller, Tatevik Ohanyan, Tomasz Hawro, et al.
The World Allergy Organization Journal|November 28, 2022
Ligelizumab improves angioedema, disease severity and quality-of-life in patients with chronic spontaneous urticariaMartin Metz, Jonathan A Bernstein, Ana M Giménez-Arnau, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|November 17, 2022
A review of cannabis allergy in the early days of legalizationAlessandro Toscano, Didier G Ebo, Khaldon Abbas, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|November 26, 2004
Canadian trial of sublingual swallow immunotherapy for ragweed rhinoconjunctivitisTom Bowen, Joseph Greenbaum, Yves Charbonneau, et al.
The Journal of Allergy and Clinical Immunology. in Practice|March 18, 2024
Beyond Confirmed Mast Cell Activation Syndrome: Approaching Patients With Dysautonomia and Related ConditionsAlexandra E Conway, Marylee Verdi, Marcus S Shaker, et al.
The New England Journal of Medicine|March 5, 2025
Remibrutinib in Chronic Spontaneous UrticariaMartin Metz, Ana Giménez-Arnau, Michihiro Hide, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|June 2, 2020
Correction to: Protocol for a double-blind, randomized controlled trial on the dose-related efficacy of omalizumab in multi-food oral immunotherapyAlexandra Langlois, Marie-Hélène Lavergne, Hélène Leroux, et al.
Clinical and Translational Allergy|August 19, 2015
ASSURE-CSU: a real-world study of burden of disease in patients with symptomatic chronic spontaneous urticariaKarsten Weller, Marcus Maurer, Clive Grattan, et al.
Pageof 7

Showing results (31-40 of 67) with videos related to

Sort By:
Pageof 7
The Journal of Allergy and Clinical Immunology. in Practice|November 20, 2020
Anti-PEG IgE in anaphylaxis associated with polyethylene glycolZhao-Hua Zhou, Cosby A Stone, Baruch Jakubovic, et al.
The Journal of Allergy and Clinical Immunology. in Practice|April 10, 2020
Omalizumab Re-Treatment and Step-Up in Patients with Chronic Spontaneous Urticaria: OPTIMA TrialGordon Sussman, Jacques Hébert, Wayne Gulliver, et al.
Allergy|August 5, 2018
Total IgE levels are linked to the response of chronic spontaneous urticaria patients to omalizumabKarsten Weller, Tatevik Ohanyan, Tomasz Hawro, et al.
The World Allergy Organization Journal|November 28, 2022
Ligelizumab improves angioedema, disease severity and quality-of-life in patients with chronic spontaneous urticariaMartin Metz, Jonathan A Bernstein, Ana M Giménez-Arnau, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|November 17, 2022
A review of cannabis allergy in the early days of legalizationAlessandro Toscano, Didier G Ebo, Khaldon Abbas, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|November 26, 2004
Canadian trial of sublingual swallow immunotherapy for ragweed rhinoconjunctivitisTom Bowen, Joseph Greenbaum, Yves Charbonneau, et al.
The Journal of Allergy and Clinical Immunology. in Practice|March 18, 2024
Beyond Confirmed Mast Cell Activation Syndrome: Approaching Patients With Dysautonomia and Related ConditionsAlexandra E Conway, Marylee Verdi, Marcus S Shaker, et al.
The New England Journal of Medicine|March 5, 2025
Remibrutinib in Chronic Spontaneous UrticariaMartin Metz, Ana Giménez-Arnau, Michihiro Hide, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|June 2, 2020
Correction to: Protocol for a double-blind, randomized controlled trial on the dose-related efficacy of omalizumab in multi-food oral immunotherapyAlexandra Langlois, Marie-Hélène Lavergne, Hélène Leroux, et al.
Clinical and Translational Allergy|August 19, 2015
ASSURE-CSU: a real-world study of burden of disease in patients with symptomatic chronic spontaneous urticariaKarsten Weller, Marcus Maurer, Clive Grattan, et al.
Pageof 7